Bli medlem
Bli medlem

Du är här


ContextVision AB : ContextVision AB presents Q1 2015

Sales growth and improved margins for ContextVision

ContextVision AB (OSE: COV), the medical imaging software company, today
announced its first quarter 2015 results. The Company's had its best quarter
in more than two years in terms of sales, and the operating margin bounced
back into double digits after a relatively weak fourth quarter.

ContextVision's sales in the first quarter were SEK 18.4 million, compared to
SEK 17.6 million in the same period last year. Operating profit ended at SEK
1.9 million in the first quarter, against SEK 1.8 million last year.
ContextVision's net profit was SEK 1.5 million, which is the same as last

ContextVision provides specialty software to a variety of medical imaging
technologies, such as ultrasound, x-ray and MRI. Approximately 70 per cent
of the Company's sales are now in the ultrasound segment, which is the
fastest growing modality in the industry. ContextVision is the technology
frontrunner in software for enhancement and analysis of 3D ultrasound, the
most sophisticated ultrasound category, opening new possibilities for
accurate diagnosis and treatment.

During the first quarter, ContextVision was awarded contracts with another
three of the industry majors in the medical imaging industry. The contracts
are expected to start generate revenue towards the end of 2015. R&D efforts
were intensified in the quarter, in order to develop the next generation
software for enhancement and analysis of medical images.

For further information, please contact ContextVision's CEO, Anita
Tollstadius, telephone +46 870 337 3026

COV Q1 2015


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ContextVision AB via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.